Close-up of a Nepali woman’s face with active acne breakouts, including red inflammatory papules, pustules, and scarring on her cheek and jawline.

Medically Reviewed by: Dr. Utsav Sharma, MD, Senior Consultant Dermatologist & Venereologist (Nepal Medical Council Reg. No. 7619)

Quick Summary:

  • Global Burden: Global Burden of Disease data cited in recent research estimates that acne vulgaris affects roughly 9.4% of the global population across all age groups, making it the eighth most prevalent disease worldwide.
  • Adult Breakouts: Epidemiological surveys indicate that 10% to 12% of adult women experience persistent or late-onset acne, frequently linked to hormonal sensitivity, dietary glycemic load, and chronic stress.
  • Four Biological Processes: Breakouts develop inside the hair follicle and oil gland unit through excess sebum production, blocked pores, shifts in Cutibacterium acnes bacteria, and localized immune inflammation.
  • Standard Care vs. Future Research: While prescription topical retinoids, benzoyl peroxide, and targeted oral medications remain the gold standard in clinical practice today, emerging approaches like bacteriophage therapy and acne vaccines are currently under investigation in clinical trials.

Acne is frequently misunderstood as a temporary teenage phase or a sign of poor facial hygiene. In clinical practice, however, persistent acne is a chronic inflammatory disorder of the skin that over-the-counter face washes rarely resolve on their own.

In 2026, dermatology and biotherapy researchers Ya Li, Guolin Li, Lian Wang, Dan Du, Jiaqi Li, Deyu Song, Tong Li, Ping Feng, Xian Jiang, and Jiong Li from West China Hospital, Sichuan University, published an extensive scientific review in the Nature Portfolio journal Signal Transduction and Targeted Therapy.

At Derma Clinic, we translate peer-reviewed dermatological research into clear, practical guidance for our patients. Below, we examine what this 2026 review reveals about the biological causes of acne, how established medical treatments compare with experimental therapies, and what steps you can take to manage breakouts safely.

What Causes Acne? The Four Main Biological Processes

Acne develops inside the pilosebaceous unit—the microscopic structure in your skin that consists of a hair follicle and its attached oil-producing (sebaceous) gland. Rather than having a single trigger, the 2026 review details how four interconnected biological processes interact to form a blemish:

Excess Sebum and Blocked Pores

  1. Androgen-Driven Sebum Production: Androgen hormones (such as testosterone and dihydrotestosterone) bind to receptors on sebaceous glands, stimulating them to produce higher volumes of sebum with an altered lipid composition.
  2. Follicular Hyperkeratinization (Clogged Pores): Normally, dead skin cells (keratinocytes) lining the pore shed smoothly onto the skin’s surface. In acne-prone skin, these cells stick together and mix with excess oil, forming a microscopic plug called a microcomedone—the precursor to visible blackheads and whiteheads.

Cutibacterium acnes and Inflammation

  1. Microbiome Imbalance (C. acnes Dysbiosis): Cutibacterium acnes (C. acnes) is a normal bacterium that lives harmlessly on healthy human skin. However, when a pore becomes blocked and oxygen-deprived, specific inflammatory strains of C. acnes lose their natural balance and multiply rapidly within the trapped oil.
  2. Innate and Adaptive Immune Inflammation: Overgrown C. acnes strains release enzymes and proteins—including Christie–Atkins–Munch-Petersen (CAMP) factors—that activate immune sensors (Toll-like receptors) on surrounding skin cells. White blood cells rush to the follicle, creating the redness, swelling, tenderness, and pus characteristic of inflammatory pimples and deep cysts.
Biological ProcessClinical TermWhat Happens Inside the Pore
1. Oil OverproductionSeborrheaHormones stimulate oil glands to secrete thick, altered sebum lipids.
2. Follicular PluggingHyperkeratinizationSticky skin cells fail to shed properly, trapping oil inside the hair follicle.
3. Bacterial ShiftC. acnes DysbiosisLoss of microbial balance allows pro-inflammatory C. acnes strains to dominate.
4. Immune ActivationPerifollicular InflammationImmune cells react to bacterial signals, causing visible redness, swelling, and pus.

Because the first two stages are driven by internal hormone signaling and cellular turnover deep within the pore lining, scrubbing the surface of your face cannot prevent microcomedones from forming. Aggressive physical scrubbing actually damages the outer skin barrier and worsens inflammation.

Common Acne Risk Factors: Hormones, Diet, Stress, and Genetics

Why do some people experience severe, scarring breakouts while others only notice occasional blemishes? Li and colleagues review several internal and external factors associated with acne severity:

  • High-Glycemic Diets and the Insulin–IGF-1 Pathway: Consuming diets high in refined sugars, white carbohydrates, and certain dairy products can spike blood glucose and insulin levels. Elevated insulin increases Insulin-like Growth Factor 1 (IGF-1)—a hormone that activates cellular signaling pathways (PI3K/Akt/mTORC1) linked to increased sebaceous gland growth and lipid production.
  • Endocrine and Metabolic Conditions: Persistent breakouts—particularly when paired with irregular menstrual cycles, excess facial or body hair, or scalp hair thinning—are frequently associated with underlying conditions such as Polycystic Ovary Syndrome (PCOS) or insulin resistance. Addressing the internal hormonal imbalance is essential to prevent recurring flare-ups.
  • Genetic Susceptibility: Family history influences sebaceous gland activity, follicular cell shedding, and how strongly an individual’s immune system responds to C. acnes.
  • Chronic Stress and Occlusive Products: Psychological stress elevates cortisol and neuropeptides near oil glands, while heavy, pore-clogging (comedogenic) cosmetics or improper sunscreens can trap cellular debris inside follicular openings.

Adult Acne vs. Teenage Acne

Global epidemiological data reviewed in the paper estimates that while acne peaks between ages 15 and 20—affecting roughly 85% of adolescents—it frequently persists into or begins during adulthood. Population studies report that 10% to 12% of adult women experience ongoing acne, with rising prevalence observed across both Western and Asian urban populations.

Clinical CharacteristicAdolescent Acne (Ages 15–20)Adult Female Acne (Ages 25+)
Estimated PrevalenceApproximately 85% of teenagers globally10% to 12% of adult women in population surveys
Typical DistributionForehead, nose, and upper cheeks (central T-zone)Often involves multiple zones, including the lower cheeks, chin, and jawline
Predominant LesionsBlackheads (open comedones), whiteheads, and surface pustulesDeep-seated, tender inflammatory papules, nodules, and cyclical cysts
Key Associated FactorsPuberty-related androgen surges and increased sebum outputHormonal fluctuations, PCOS, chronic stress, and skin barrier sensitivity

Beyond physical blemishes, the review highlights that acne affects daily quality of life in up to 90% of patients studied, with over half reporting anxiety, reduced self-esteem, or depressive symptoms.

Established Acne Treatments vs. Emerging Research

One of the most important takeaways for patients reading scientific news is understanding the difference between established medical treatments available in dermatology clinics today and experimental therapies still undergoing clinical trials.

Topical Retinoids, Benzoyl Peroxide, and Antibiotic Stewardship

A major focus of the 2026 review is the global rise of antibiotic-resistant C. acnes strains caused by the long-term use of standalone antibiotic creams or pills (such as erythromycin, clindamycin, and tetracyclines). Using a topical antibiotic by itself allows bacteria to adapt quickly and disrupts beneficial skin flora.

Current international dermatology guidelines rely on proven, multi-targeted acne treatments:

  • Topical Retinoids (e.g., Adapalene, Tretinoin): Normalize cell turnover to prevent pore plugging and reduce inflammation.
  • Benzoyl Peroxide: Releases oxygen radicals inside the pore to kill C. acnes bacteria without inducing bacterial drug resistance.
  • Azelaic and Salicylic Acids: Help clear follicular debris and calm post-inflammatory pigmentation.
  • Systemic Therapies: Short-course oral antibiotics (always paired with benzoyl peroxide), hormonal anti-androgens for eligible female patients, or physician-monitored oral isotretinoin for severe, nodulocystic, or scarring acne.

Microencapsulation, Phage Therapy, and Vaccines (Under Investigation)

To overcome skin irritation and antibiotic resistance, researchers are investigating several next-generation technologies:

  • Microencapsulated Drug Delivery: Wrapping active ingredients like retinoids or benzoyl peroxide inside microscopic lipid or silica shells so they release slowly into the follicle, reducing surface dryness and stinging.
  • Bacteriophage Therapy: Using targeted viruses (“phages”) formulated in topical gels to selectively destroy acne-associated C. acnes strains without harming beneficial skin bacteria.
  • CAMP Factor Vaccines: Experimental immunization approaches designed to neutralize the specific inflammatory proteins secreted by C. acnes rather than eradicating the bacterium itself.

Comparison: Standard Clinical Care vs. Investigational Approaches

Treatment ApproachCurrent Clinical StatusPrimary MechanismKey Limitations & Considerations
Topical Retinoids + Benzoyl PeroxideEstablished Standard of Care (Widely available)Unclogs pores, normalizes cell shedding, and eliminates bacteria without resistanceCan cause initial dryness or peeling; requires consistent use for 8–12 weeks; retinoids must be avoided in pregnancy.
Oral Isotretinoin / Hormonal TherapyEstablished Specialist Care (Prescription only)Shrinks oil glands and reduces sebum output in severe or hormonally driven acneRequires strict dermatologist monitoring, blood tests, and absolute pregnancy prevention (for isotretinoin).
Microencapsulated TopicalsEarly Clinical Adoption (Select formulations available)Slow, controlled delivery of established actives into the hair follicleImproves skin tolerance, though availability and cost vary by region.
Bacteriophage Gels & ProbioticsEmerging Research (Early-phase clinical trials)Selectively targets resistant C. acnes strains and supports microbiome balanceNot yet part of routine clinical guidelines; long-term efficacy data is still being gathered.
Targeted Acne Vaccines (CAMP)Preclinical / Investigational (Experimental stage)Neutralizes bacterial inflammatory toxins without killing commensal bacteriaRemains in experimental research; not currently available for patient treatment.

Clinical Perspective: What This Means for Patients in Nepal

Clinical Note from Dr. Utsav Sharma (Senior Consultant Dermatologist, NMC No. 7619):

“In our daily practice at Derma Clinic in Kathmandu, one of the most common challenges we see is patients self-medicating with over-the-counter antibiotic gels—or worse, unprescribed combination steroid creams—purchased from local pharmacies. As the 2026 Nature review highlights, standalone antibiotics quickly lose effectiveness due to bacterial resistance, while steroid creams thin the skin and trigger severe rebound breakouts (steroid-induced rosacea and acne). Effective acne care does not require waiting for future vaccines; we already have highly effective, guideline-backed treatments today. The key is matching the right active ingredients to your skin’s barrier tolerance and ruling out underlying triggers like PCOS.”

When Should You See a Dermatologist for Acne?

While very mild, occasional whiteheads may respond to a gentle cleanser and non-comedogenic moisturizer, professional dermatological evaluation is recommended if you experience:

  • No Improvement After 8 to 12 Weeks: Most evidence-based topical treatments take 8 to 12 weeks of consistent use to show visible clearing.
  • Deep, Painful Nodules or Cysts: Under-the-skin lumps indicate deep follicular inflammation that topical washes cannot reach.
  • Early Signs of Scarring or Dark Marks: Pitted scars or persistent dark spots (post-inflammatory hyperpigmentation, which is especially common in South Asian skin tones) are much easier to prevent than to reverse.
  • Signs of Hormonal Imbalance: Breakouts concentrated along the lower jawline paired with irregular periods or excess hair growth.

Frequently Asked Questions (FAQs) About Acne

Does washing my face more often cure acne?

No. Clinical research shows that acne begins beneath the skin’s surface due to hormone-stimulated sebum production, sticky follicular cells, and immune inflammation. Washing more than twice daily or using rough scrubs strips your protective skin barrier and worsens irritation.

Why am I still getting acne in my late 20s, 30s, or 40s?

Adult acne—particularly in women—is commonly linked to heightened oil-gland sensitivity to normal androgen levels, dietary glycemic spikes, chronic stress, or endocrine conditions like PCOS. Because adult skin often has a more delicate barrier than teenage skin, it requires a tailored medical regimen rather than harsh drying lotions.

How long does medical acne treatment take to work?

Because a microscopic clogged pore (microcomedone) takes several weeks to form and surface, most prescription topical regimens require 6 to 8 weeks before noticeable improvement begins, and 3 to 6 months for sustained clearance. Stopping treatment after a few days or switching products too frequently prevents the skin from healing.

Why shouldn’t I use leftover antibiotic creams on my pimples?

Applying standalone antibiotic creams encourages Cutibacterium acnes bacteria to develop drug resistance and disrupts healthy skin bacteria. When dermatologists prescribe antibacterials, they pair them with agents like benzoyl peroxide or retinoids to prevent resistance and target multiple causes of acne simultaneously.

Conclusion and Next Steps for Clearer Skin

The 2026 Signal Transduction and Targeted Therapy review reinforces a central principle of modern dermatology: acne is a multifactorial medical condition, not a simple surface blemish. While exciting innovations like bacteriophage therapy and targeted vaccines are progressing through scientific trials, patients do not need to wait for experimental therapies to achieve clear skin.

Today’s established medical treatments—when properly selected for your acne severity, hormone profile, and skin type—can safely control breakouts, protect your skin microbiome, and prevent permanent scarring.

If you are struggling with persistent teen or adult breakouts, hormonal flare-ups, or post-acne scarring, our dermatology team at Derma Clinic in Kathmandu provides evidence-based clinical evaluations. You can explore our Acne Treatment Services in Kathmandu or book a clinical consultation with Dr. Utsav Sharma for an individualized treatment plan.

References and Medical Review

  • Primary Study Reviewed: Li, Y., Li, G., Wang, L., Du, D., Li, J., Song, D., Li, T., Feng, P., Jiang, X., & Li, J. (2026). Acne: epidemiology, risk factors, pathogenesis, management and cutting-edge research. Signal Transduction and Targeted Therapy (Nature Portfolio / Springer Nature), Volume 11, Article Number: 446.
  • Official Publisher Link: https://www.nature.com/articles/s41392-026-02964-2 | DOI: 10.1038/s41392-026-02964-2
  • Clinical Reviewer: Dr. Utsav Sharma, MD Dermatology, Venereology & Leprology (NMC Reg. No. 7619), Senior Consultant Dermatologist at Derma Clinic PVT LTD, Kathmandu, Nepal.
  • Editorial & Copyright Disclosure: This article is an original educational synthesis and clinical commentary written for patients. Epidemiological figures (such as global prevalence estimates from the Global Burden of Disease study) and emerging research summaries are attributed to the cited review paper. No copyrighted text, figures, or tables from the original publication (CC BY-NC-ND 4.0) have been reproduced.